3. EQD2 (α/β 0.58).
| Study | Hypofractionation | Dose per fraction |
EQD2 (α/β = 0.58 prostate cancer) |
Conventional | Dose per fraction |
EQD2 α/β = 0.58 prostate cancer |
| Arcangeli 2010 | 62 Gy/20 fractions | 3.1 | 88.23 | 80 Gy/40 fractions | 2 | 80 |
| CHHiP 2016 | 60 Gy/20 fractions 57 Gy/19 fractions |
3 | 83.08 78.92 |
74 Gy/37 fractions | 2 | 74 |
| Fox Chase 2013 | 70.2 Gy/26 fractions | 2.7 | 89.1 | 76 Gy/38 fractions | 2 | 76 |
| HYPRO Dutch 2016 | 64.6 Gy/19 fractions | 3.4 | 99.38 | 78 Gy/39 fractions | 2 | 78 |
| Lee 2016 | 70 Gy/28 fractions | 2.5 | 83.46 | 73.8 Gy/41 fractions | 1.8 | 68.12 |
| Lukka NCIC 2005 | 52.5 Gy/20 fractions | 2.6 | 64 | 66 Gy/33 fractions | 2 | 66 |
| MDACC 2014 | 72 Gy/30 fractions | 2.4 | 83.08 | 75.6 Gy/42 fractions | 1.8 | 69.78 |
| Norkus 2009 | 57 Gy/17 fractions | 3.35 | 70.62 | 74 Gy/37 fractions | 2 | 74 |
| PROFIT 2016 | 60 Gy/20 fractions | 3 | 83.08 | 78 Gy/39 fractions | 2 | 78 |
| Yeoh 2011 | 55 Gy/20 fractions | 2.75 | 73.23 | 64 Gy/32 fractions | 2 | 64 |
EQD2: equivalent dose in 2 Gy fractions.